| Literature DB >> 31472953 |
Weronika Andrzejewska1, Michalina Wilkowska1, Barbara Peplińska2, Andrzej Skrzypczak3, Maciej Kozak4.
Abstract
For several years cationic surfactants have been the subjects of extensive studies as potential transgene carriers to be used in gene therapy. We report the formation of stable complexes between 21 base pairs oligonucleotides - siRNA, enhancing DMPK gene, and dsDNA and two tricationic surfactants (1,2,3-propanetri[oxymethyl-3-(1-dodecylimidazolium)]chloride and 1,2,3-propanetri[(oxymethyl)dimethyldodecylammonium]chloride. Structural studies by SAXS and TEM have shown that the dominant structure of the obtained lipoplexes is based on hexagonal, lamellar and cubic phases, packed in highly ordered aggregates. It has been established that tricationic surfactants can be used as siRNA carriers in gene therapy.Entities:
Keywords: DMPK; Gene therapy; SAXS; Tricationic surfactants; dsDNA; siRNA
Mesh:
Substances:
Year: 2019 PMID: 31472953 DOI: 10.1016/j.bbrc.2019.08.114
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575